Kevin M. Friedman

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Noopur Raje, Jesús G. Berdeja, Yi Lin et al. · New England Journal of Medicine · 2019 · 1.7K citations · Full text

Effective Targeting of Multiple B-Cell Maturation Antigen–Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells

Kevin M. Friedman, Tracy E. Garrett, John Evans et al. · Human Gene Therapy · 2018 · 203 citations

Lymphocyte Development, Adaptive Immune System, Immunology +23

Selective Inhibition of Regulatory T Cells by Targeting the PI3K–Akt Pathway

Rasha Abu Eid, Raed Samara, Laurent Ozbun et al. · Cancer Immunology Research · 2014 · 148 citations · Full text

Pi3k Inhibitors, T-regulatory Cell, Immune Regulation +22

Tumor-specific CD4+ Melanoma Tumor-infiltrating Lymphocytes

Kevin M. Friedman, Peter A. Prieto, Laura Devillier et al. · Journal of Immunotherapy · 2012 · 102 citations · Full text

Specific Reactivity, Cell Therapy, Immunology +19

The ISG15 Isopeptidase UBP43 Is Regulated by Proteolysis via the SCFSkp2 Ubiquitin Ligase

Sara Tokarz, Catherine Berset, Janna La Rue et al. · Journal of Biological Chemistry · 2004 · 54 citations · Full text

Type 1, Protein Function, Cell Regulation +15